Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04893460 · ClinicalTrials.gov registry record · NA
CoQuit Study for Smoking Cessation
A NA study, sponsored by Oregon Research Behavioral Intervention Strategies.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT04893460: Completed NA study, sponsored by Oregon Research Behavioral Intervention Strategies.
NCT04893460 is a NA study that has completed, run by Oregon Research Behavioral Intervention Strategies. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04893460, a NA study, has completed, sponsored by Oregon Research Behavioral Intervention Strategies.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
This study investigated the feasibility of a cognitive dissonance-based mobile app for smoking cessation (CDI). Cognitive dissonance refers to the conflict between beliefs and behaviors; interventions are designed to promote this conflict to motivate people to change their behavior. Recent research has demonstrated the efficacy and potential of using cognitive dissonance interventions for a wide range of health and behavioral problems including smoking cessation. This study developed an initial version of the CDI mobile app and evaluated the app in an evaluation study with 60 adult smokers.
Primary Outcome
Participants were asked to give a "gut-level response" to 14 words used to describe various attributes of cognitive dissonance (e.g., uncomfortable, shame). Response options for each attribute were on a 7-point scale (1 = does not apply at all, 7 = applies very much). A mean score was computed across all 14 words. A higher score was associated with greater levels of cognitive dissonance. In addition to the baseline and six-week follow-up assessment of cognitive dissonance, participants were aske
Interventions
- BEHAVIORAL CoQuit App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2021-09-29 |
| Phase | NA |
What the finished NCT04893460 record still lists
NCT04893460 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which CoQuit App is the first listed.
NCT04893460 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04893460 about?
NCT04893460 is a clinical study titled "CoQuit Study for Smoking Cessation". This study investigated the feasibility of a cognitive dissonance-based mobile app for smoking cessation (CDI). Cognitive dissonance refers to the conflict between beliefs and behaviors; interventions are designed to promote this conflict to motivate people to change their behavior. Recent research ...
What is the current status of trial NCT04893460?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2021-06-01. Estimated completion is 2021-09-29.
What interventions are being tested in trial NCT04893460?
The interventions under investigation include: CoQuit App (BEHAVIORAL).
Who is sponsoring clinical trial NCT04893460?
This trial is sponsored by Oregon Research Behavioral Intervention Strategies, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04893460's enrollment target sits among peer trials
72 1089th of 2000 higher than 899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI